Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain

by Ben Anderson | Apr 19, 2023 | news

MINNEAPOLIS – April 19, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that it has completed the close of its $50 million Series G financing....

Relievant Medsystems Receives 2023 Gallup Exceptional Workplace Award

by Ben Anderson | Mar 30, 2023 | news

MINNEAPOLIS – March 30, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that it has received the 2023 Gallup Exceptional Workplace Award (GEWA)...

Relievant Medsystems Announces Positive Local Coverage Determination by Palmetto GBA for Basivertebral Nerve Ablation in Treating Chronic Vertebrogenic Low Back Pain

by Ben Anderson | Mar 6, 2023 | news

MINNEAPOLIS – March 6, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that Palmetto GBA has published a final Local Coverage Determination...

Relievant Medsystems Announces Formal Coverage Recommendation from NASS for Basivertebral Nerve Ablation as a Treatment for Chronic Vertebrogenic Low Back Pain

by Ben Anderson | Feb 22, 2023 | news

MINNEAPOLIS – February 22, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the North American Spine Society (NASS) issued a formal coverage...

Relievant Medsystems Announces Highest Quality of Evidence Ranking for Basivertebral Nerve Ablation in ASPN Back Guideline for Interventional Low Back Pain Treatments

by Ben Anderson | Jan 5, 2023 | news

MINNEAPOLIS – January 5, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that basivertebral nerve (BVN) ablation received a Grade A Quality of...

Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery

by Ben Anderson | Nov 8, 2022 | news

MINNEAPOLIS – November 8, 2022 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the International Society for the Advancement of Spine Surgery...